Revvity EBITDA 2010-2024 | RVTY

Revvity annual and quarterly EBITDA history from 2010 to 2024. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
  • Revvity EBITDA for the quarter ending September 30, 2024 was $0.195B, a 3.08% increase year-over-year.
  • Revvity EBITDA for the twelve months ending September 30, 2024 was $0.712B, a 16.03% decline year-over-year.
  • Revvity 2023 annual EBITDA was $0.74B, a 39.48% decline from 2022.
  • Revvity 2022 annual EBITDA was $1.222B, a 24.08% decline from 2021.
  • Revvity 2021 annual EBITDA was $1.61B, a 49.89% increase from 2020.
Revvity Annual EBITDA
(Millions of US $)
2023 $740
2022 $1,222
2021 $1,610
2020 $1,074
2019 $601
2018 $527
2017 $409
2016 $397
2015 $365
2014 $279
2013 $361
2012 $237
2011 $212
2010 $249
2009 $200
Revvity Quarterly EBITDA
(Millions of US $)
2024-06-30 $195
2024-03-31 $154
2023-12-31 $184
2023-09-30 $179
2023-06-30 $189
2023-03-31 $187
2022-12-31 $243
2022-09-30 $229
2022-06-30 $360
2022-03-31 $390
2021-12-31 $399
2021-09-30 $258
2021-06-30 $411
2021-03-31 $542
2020-12-31 $419
2020-09-30 $312
2020-06-30 $236
2020-03-31 $107
2019-12-31 $205
2019-09-30 $141
2019-06-30 $151
2019-03-31 $105
2018-12-31 $165
2018-09-30 $126
2018-06-30 $142
2018-03-31 $94
2017-12-31 $126
2017-09-30 $105
2017-06-30 $102
2017-03-31 $77
2016-12-31 $118
2016-09-30 $101
2016-06-30 $92
2016-03-31 $86
2015-12-31 $72
2015-09-30 $104
2015-06-30 $98
2015-03-31 $91
2014-12-31 $11
2014-09-30 $88
2014-06-30 $99
2014-03-31 $81
2013-12-31 $129
2013-09-30 $92
2013-06-30 $73
2013-03-31 $67
2012-12-31 $5
2012-09-30 $75
2012-06-30 $83
2012-03-31 $74
2011-12-31 $14
2011-09-30 $65
2011-06-30 $67
2011-03-31 $66
2010-12-31 $76
2010-09-30 $65
2010-06-30 $57
2010-03-31 $51
2009-12-31 $55
2009-09-30 $36
2009-06-30 $61
2009-03-31 $48
Sector Industry Market Cap Revenue
Medical Medical Services $15.535B $2.751B
Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $96.890B 12.02
Cencora (COR) United States $46.107B 17.62
DiDi Global (DIDIY) China $23.233B 0.00
ICON (ICLR) Ireland $18.679B 16.64
Avantor (AVTR) United States $15.498B 23.24
Natera (NTRA) United States $15.385B 0.00
Viatris (VTRS) United States $13.858B 4.22
BioMerieux (BMXMF) France $13.601B 0.00
Solventum (SOLV) United States $12.636B 0.00
CochLear (CHEOY) Australia $12.565B 0.00
Medpace Holdings (MEDP) United States $10.202B 28.74
Charles River Laboratories (CRL) United States $9.742B 18.41
Sonic Healthcare (SKHHY) Australia $8.273B 0.00
HealthEquity (HQY) United States $7.792B 42.29
Doximity (DOCS) United States $7.787B 49.34
Bausch + Lomb (BLCO) Canada $6.975B 32.47
Life Times (LTH) United States $4.762B 31.52
PACS (PACS) United States $4.502B 0.00
Sotera Health (SHC) United States $4.367B 23.36
Organon (OGN) United States $4.239B 4.28
Surgery Partners (SGRY) United States $3.778B 41.86
BrightSpring Health Services (BTSG) United States $3.070B 65.30
Ardent Health Partners (ARDT) United States $2.577B 0.00
Alignment Healthcare (ALHC) United States $2.546B 0.00
Concentras Parent (CON) United States $2.480B 0.00
Premier (PINC) United States $2.271B 11.34
GoodRx Holdings (GDRX) United States $2.254B 84.86
GeneDx Holdings (WGS) United States $2.057B 0.00
Ryman Healthcare (RYHTY) New Zealand $2.036B 0.00
Teladoc Health (TDOC) United States $1.575B 0.00
AMN Healthcare Services Inc (AMN) United States $1.507B 7.57
Progyny (PGNY) United States $1.425B 25.06
Establishment Labs Holdings (ESTA) $1.338B 0.00
Pediatrix Medical (MD) United States $1.319B 12.91
CareDx (CDNA) United States $1.228B 0.00
Agilon Health (AGL) United States $1.123B 0.00
Embecta (EMBC) United States $0.864B 5.76
InnovAge Holding (INNV) United States $0.822B 0.00
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
SBC Medicals (SBC) United States $0.722B 0.00
Auna S.A (AUNA) Luxembourg $0.488B 0.00
Sonida Senior Living (SNDA) United States $0.483B 0.00
Enhabit (EHAB) United States $0.382B 33.04
DocGo (DCGO) United States $0.355B 13.35
COMPASS Pathways (CMPS) United Kingdom $0.309B 0.00
Sera Prognostics (SERA) United States $0.255B 0.00
ModivCare (MODV) United States $0.232B 7.37
Beauty Health (SKIN) United States $0.211B 0.00
Biodesix (BDSX) United States $0.195B 0.00
LifeMD (LFMD) United States $0.192B 0.00
Ascend Wellness Holdings (AAWH) United States $0.178B 0.00
MultiPlan (MPLN) United States $0.136B 0.00
Nutex Health (NUTX) United States $0.127B 0.00
So-Young (SY) China $0.092B 22.35
Harvard Apparatus Regenerative Technology (HRGN) United States $0.059B 0.00
Singular Genomics Systems (OMIC) United States $0.057B 0.00
OncoCyte (OCX) United States $0.049B 0.00
NeueHealth (NEUE) United States $0.041B 1.63
Co-Diagnostics (CODX) United States $0.039B 0.00
IceCure Medical (ICCM) Israel $0.036B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.027B 0.00
Pheton Holdings (PTHL) China $0.027B 0.00
Oncology Institute (TOI) United States $0.021B 0.00
SeaStar Medical Holding (ICU) United States $0.012B 0.00
XWELL (XWEL) United States $0.009B 0.00
Intelligent Bio Solutions (INBS) United States $0.007B 0.00
BioNexus Gene Lab (BGLC) $0.007B 0.00
KindlyMD (KDLY) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.003B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00